• Home
  • News
  • Press Releases

Rubicon Genomics Licenses Commercialization Rights from SomaGenics for Its RealSeq®-AC Technology for High-Throughput Sequencing of Small RNAs

Santa Cruz, Calif. July 28 2016- SomaGenics Inc. today announced that it has signed a licensing agreement with Rubicon Genomics, Inc. for commercialization of SomaGenics’ RealSeq®-AC library preparation technology for sequencing small RNAs, including micro-RNAs and small fragments of large RNAs. Further terms of the agreement were not disclosed.

The RealSeq®-AC platform is a novel technology that dramatically reduces sequencing bias compared to standard methods for preparing libraries for small RNA sequencing. RealSeq®-AC allows detection and discovery of many small RNAs that are often underestimated by up to 104-fold of their true abundance.

Continue Reading

Somagenics Awarded Second NIH Grant to Develop resQ-RNA™ Technology to Quantify Fragmented mRNA From Degraded Samples

SANTA CRUZ, Calif., February 9, 2016 – Somagenics has been awarded a second phase I SBIR grant from NIH to develop its resQ-RNA technology for quantitative real-time PCR of fragmented RNA samples.

Fragmentation of RNA is a particular problem in tissue samples that have been preserved and stored (e.g., formaldehyde-fixed, paraffin-embedded [FFPE] specimens) or collected under sub-optimal conditions (forensic samples or biofluids containing RNases). Fragmentation greatly limits the information that can be extracted from RNA samples using current methods of analysis, including the most accurate method, real-time quantitative PCR (qPCR), as the fragments can become shorter than the minimum length required for this technology.

Continue Reading